随着蒙医药临床与实验科学的快速发展，关于肝损伤的实验研究也逐渐增多，其研究内容从最初的药物对实验动物生化指标的影响发展到组织病理形态学改变以及分子生物，免疫蛋白测定等。本文章通过查阅与总结从1992年至今关于蒙药治疗肝损伤实验研究，总结多种蒙药复方、单药及其提取物对不同模型导致肝损伤的作用及影响，为蒙药治疗肝损伤的进一步研究发展提供最初的信息资源。

With the rapid development of clinical and experimental science in Mongolian medicine, experimental research on liver injury has gradually increased, and its research content has evolved from the impact of the initial drugs on the biochemical indexes of experimental animals to histopathological morphological changes and molecular biology, immunoprotein determination, etc. This paper reviewed and summarized the experimental research on Mongolian medicine treatment of liver injury from 1992 to present, summarized the effects of various Mongolian medicine prescriptions, single drugs and their extracts on liver injury caused by different models, and provide initial information resources for further development of Mongolian medicine for liver injury.

R29

内蒙古科技厅自然科学蒙药给旺-9对D-氨基半乳糖致大鼠急性肝损伤的保护作用及其炎症调控机制（2015BS080），负责人：王月洪；内蒙古医科大学博时启动基金项目（YKD2017BQ001）：蒙药给旺-9干预氨基半乳糖诱到大鼠肝损害的实验研究，负责人：王月洪。